After-Hours Movers 1/12: ZymoGenetics (ZGEN), ShengdaTech (SDTH), Humana (HUM) Higher; Parlux (PARL), Rogers (ROG) Lower
More News related to AA
- Alcoa's Kawneer Architectural Aluminum Products Enhance Learning in an Environmentally Friendly Way
- Alcoa to Rebuild, Enhance Forging Press in Cleveland
- Alcoa Partners with His Royal Highness The Prince of Wales' Rainforests Project
- ETF Movers: XLF, XLB, TAN, USO, GLD Up; FAZ, IYT, KRE Lower
- Alcoa Highlights Sustainable Aluminum Design for Building and Construction Industry at Greenbuild 2009
More News related to BMY
- Notable ETF Movers: PGM, XLV, SMH Up; UNG, KRE, FXI, AGQ, XME Down
- Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference
- Bristol-Myers Squibb (BMY) and Alder Biopharma Agree to Develop Rheumatoid Arthritis Treatment
- Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
- Emerging Stock Report Initiates Independent Research Coverage On Human Genome Sciences
More News related to CSX
- CSXT Continues to Invest in New Technology to Drive Efficiency and a Reduction in Emissions
- CSX and City Year Send 150 Volunteers to Charleston for "Give a Day, Change the World"
- CSX Becomes First Transportation Provider to Join Maryland Green Registry
- CSX Corporation Chief Transportation Officer to Address Citi Investment Research Transportation Conference
- Notable Analyst Rating Changes: CSX, UNH, DF, TS Upgraded; SNDK, INTC, VALE Upgraded
More News related to Special Reports
- Notable ETF Movers: XLF, XHM, AGQ, SGG Up; IEO, EWU, TBT Down
- Notable Analyst Rating Changes 11/11: SMI, TOL, SFD, MCHP Upgraded; PCLN, SNV, RHIE, ADBE, SIGM, HUM Downgraded
- Notable Mergers and Acquisitions of the Day 11/11: BIN/WSII, NCST/SNN, SYK/SURG, LOGI/LifeSize
- Morning Movers 11/11: NCST, SMI, MSN, CHLN, NLST, REGN Higher; TGIC, STS, CLWR, STV, MHR, MBLX Lower
- After-Hours Movers 11/10: BITS, GSB, OCNF, HOO Higher; TGIC, MCZ, STV, MBLX, EM Lower
ZymoGenetics, Inc. (Nasdaq: ZGEN) 28% HIGHER; Bristol-Myers Squibb Company (NYSE: BMY) and ZymoGenetics announced a global collaboration for PEG-Interferon lambda, a novel type 3 interferon currently in Phase Ib development for the treatment of Hepatitis C, and its related development program. Click here for the full report.
Parlux Fragrances, Inc. (NASDAQ: PARL) 10% LOWER; reports preliminary Q3 sales of $47.3 million, versus the Street estimate of $55.30 million.
ShengdaTech, Inc. (Nasdaq: SDTH) 3.5% HIGHER; announced that the Company continues its efforts to close on the acquisition of Jinan Fertilizer Co., Ltd. and now anticipates that the acquisition is expected to be accomplished during Q109.
Rogers Corporation (NYSE: ROG) 3.1% LOWER; lowers its Q4 sales guidance from $88-$92 million to $78-$79 million, versus the consensus of $85 million. Non-GAAP EPS for the quarter move from $0.50-$0.56 to $0.43-$0.49, versus the Street estimate of $0.39.
PAREXEL (Nasdaq: PRXL) 2.3% LOWER; cuts its Q2 and FY09 guidance. Click here for the full report.
Humana (NYSE: HUM) 2% HIGHER; intends to reaffirm its previously issued FY08 EPS guidance of $3.80-$3.90, versus the consensus of $4.28. For FY09, Humana backs its prior guidance of $5.90-$6.10, versus the Street estimate of $5.92.
KLA-Tencor Corporation (NASDAQ: KLAC) 1.5% LOWER; sees Q2 revenue $390 - $400 million, below the consensus of $415.66 million. Click here for the full report.
Alcoa (NYSE: AA) 1% HIGHER; reports Q4 loss of $0.28, ex-items, 18 cents worse than the analyst estimate of ($0.10). Revenue for the quarter was $5.7 billion, versus the consensus of $5.26 billion.
CSX Corporation (NYSE: CSX) 1% LOWER; reports preliminary Q4 EPS of $0.90, ex-items, versus the consensus of $0.98. Overall revenues are expected to be about $2.7 billion in Q4, up 4% from the same period last year, and compared to the Street estimate of $2.77 billion.
To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.
Related Categories
Special ReportsStocks Mentioned
+0.03
-0.41Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
